Von Willebrand factor, Immunology, Internal medicine, Platelet and Endocrinology are his primary areas of study. His Von Willebrand disease and Ristocetin study are his primary interests in Von Willebrand factor. His work in the fields of Immunology, such as Platelet membrane glycoprotein, intersects with other areas such as In patient.
His Internal medicine study combines topics in areas such as Gastroenterology and Immunoelectrophoresis. His work carried out in the field of Platelet brings together such families of science as Hemostasis, Molecular biology, Biochemistry and Antibody. His Endocrinology study combines topics in areas such as Centrifugation and Antigen.
His primary scientific interests are in Von Willebrand factor, Immunology, Platelet, Von Willebrand disease and Internal medicine. His studies deal with areas such as Molecular biology, Recombinant DNA, Antigen and Protein precursor as well as Von Willebrand factor. Within one scientific family, Robert R. Montgomery focuses on topics pertaining to Genetic enhancement under Immunology, and may sometimes address concerns connected to Haematopoiesis and Platelet transfusion.
Robert R. Montgomery has included themes like Hemostasis, Genetically modified mouse and Antibody in his Platelet study. His Von Willebrand disease research includes elements of Desmopressin, Phenotype, Mutation, Exon and Pediatrics. His Internal medicine research integrates issues from Gastroenterology and Endocrinology.
The scientist’s investigation covers issues in Von Willebrand factor, Von Willebrand disease, Immunology, Platelet and Internal medicine. His biological study spans a wide range of topics, including Protein precursor, Molecular biology, Platelet membrane glycoprotein, Hemostasis and Pediatrics. His Von Willebrand disease research is multidisciplinary, incorporating elements of Genetics, Antigen, Cohort and Ristocetin.
His research integrates issues of Phenotype, Gene, Genetic enhancement, Coagulation and Pharmacology in his study of Immunology. As part of the same scientific family, Robert R. Montgomery usually focuses on Platelet, concentrating on In vivo and intersecting with Octapharma. Robert R. Montgomery combines subjects such as Gastroenterology and Endocrinology with his study of Internal medicine.
Robert R. Montgomery mainly investigates Von Willebrand factor, Immunology, Platelet, Von Willebrand disease and Phenotype. His Von Willebrand factor study deals with the bigger picture of Internal medicine. Robert R. Montgomery has researched Immunology in several fields, including Molecular biology and Haematopoiesis.
The concepts of his Platelet study are interwoven with issues in Predictive value of tests and Genetic enhancement. In his study, Ristocetin cofactor assay, Desmopressin and Pediatrics is strongly linked to Cohort, which falls under the umbrella field of Von Willebrand disease. His work investigates the relationship between Phenotype and topics such as Coagulation that intersect with problems in Recombinant DNA, Antigen, Gel electrophoresis, Immune system and Endothelial stem cell.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council
Roger Chou;Debra B. Gordon;Oscar A. De Leon-Casasola;Jack M. Rosenberg.
The Journal of Pain (2016)
The effect of ABO blood group on the diagnosis of von Willebrand disease
Joan Cox Gill;Janet Endres-Brooks;Patricia J. Bauer;William J. Marks.
Blood (1987)
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor
J E Sadler;U Budde;J C J Eikenboom;E J Favaloro.
Journal of Thrombosis and Haemostasis (2006)
von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).
W. L. Nichols;M. B. Hultin;A. H. James;M. J. Manco‐Johnson.
Haemophilia (2008)
The comprehensive microbial resource
Tanja Davidsen;Erin Beck;Anuradha Ganapathy;Robert Montgomery.
Nucleic Acids Research (2001)
Platelets have more than one binding site for von Willebrand factor.
Z M Ruggeri;L De Marco;L Gatti;R Bader.
Journal of Clinical Investigation (1983)
Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets.
D Pidard;R R Montgomery;J S Bennett;T J Kunicki.
Journal of Biological Chemistry (1983)
Laparoscopic assisted live donor nephrectomy--a comparison with the open approach.
Lloyd E. Ratner;Louis R. Kavoussi;Myrna Sroka;Janet Hiller.
Transplantation (1997)
T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates.
Jay E. Menitove;Richard H. Aster;James T. Casper;Stephen J. Lauer.
The New England Journal of Medicine (1983)
Autoantibodies against platelet glycoprotein Ib in patients with chronic immune thrombocytopenic purpura.
Virgil L. Woods;Yoshiyuki Kurata;Robert R. Montgomery;Patricia Tani.
Blood (1984)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Medical College of Wisconsin
Johns Hopkins University
Scripps Research Institute
Medical College of Wisconsin
Nuvu2, Inc.
Johns Hopkins University School of Medicine
University of Colorado Anschutz Medical Campus
Medical College of Wisconsin
Children's Hospital of Philadelphia
Medical College of Wisconsin
Ghent University
Lehigh University
University of California, San Francisco
University of Delaware
Federal University of Toulouse Midi-Pyrénées
Pohang University of Science and Technology
Aarhus University
University of Copenhagen
University of Alaska Fairbanks
Spanish National Research Council
Korea University of Science and Technology
Tokyo Medical University
Vanderbilt University Medical Center
National Cancer Institute
Emory University
University of St Andrews